Treating Hyperpigmentation in Darker Skin Types: The Expert Weighs In
Essence recently posted an article on how to treat hyperpigmentation on melanated skin. What cosmetic ingredients make the most impact in treating hyperpigmentation in darker skin types? What are the challenges that skin of color poses when treating hyperpigmentation?
For expert advice, I reached out to Miami dermatologist Heather Woolery-Lloyd, MD. She will address hyperpigmentation and other …
Essence recently posted an article on how to treat hyperpigmentation on melanated skin. What cosmetic ingredients make the most impact in treating hyperpigmentation in darker skin types? What are the challenges that skin of color poses when treating hyperpigmentation?
For expert advice, I reached out to Miami dermatologist Heather Woolery-Lloyd, MD. She will address hyperpigmentation and other … Continue reading "Treating Hyperpigmentation in Darker Skin Types: The Expert Weighs In"
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Cheryl Burgess, medical director of the Center for Dermatology in Washington, D.C., and an assistant clinical professor of dermatology at Georgetown University, Washington, D.C. Dr. Burgess explains the filler complications that are more common in patients with skin of color, and the questions you should ask before you … 
A study on the safety of UV lights during gel manicures is the most popular dermatology topic in the consumer press this month. Dermatologists have long been concerned that routine gel manicures with UV lights would be associated with a higher risk of skin cancer. A study in Nature Communications demonstrates that the radiation emitted by these UV nail polish dryers does damage DNA and cause perma … 
INTRODUCTION
Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Vishal A. Patel (fellowship trained Mohs micrographic surgeon who serves as Director of Cutaneous Oncology at the GW Cancer Center and Director of Dermatologic Surgery at the GW Department of Dermatology) about routine skin cancer checks. Watch as he provides insight on this complex questio … 